LINC01979: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01979

NCBI ID: G101928766

LINC01979

Other Name(s): long intergenic non-protein coding RNA 1979 | Long intergenic non-protein coding RNA 1979

LINC01979: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC01979 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is located between the genes P000 and P001 on chromosome 16, and it has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion.

The discovery of LINC01979 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases. LINC01979 is a good candidate for a drug because it has been shown to interact with several protein molecules, including the protein known as PD-L1. PD-L1 is a protein that is expressed in many tissues and has been shown to promote the development of cancer. By blocking the interaction between LINC01979 and PD-L1, a drug could potentially inhibit the growth and spread of cancer cells.

Another potential mechanism by which LINC01979 could be used as a drug target is its role in cell adhesion. LINC01979 has been shown to play a role in the formation of tight junctions, which are a type of cell-cell adhesion structure. By interfering with the formation of tight junctions, a drug could potentially inhibit the ability of cells to stick together and could lead to the formation of new tumors.

In addition to its potential role as a drug target, LINC01979 has also been identified as a potential biomarker. The expression of LINC01979 has been shown to be downregulated in a variety of tissues and conditions, including cancer. By measuring the level of LINC01979 in tissues, researchers may be able to monitor the effectiveness of a drug or treatment. Additionally, LINC01979 has been shown to be downregulated in the blood vessels of individuals with certain types of cancer, which may be an indication that it could be a useful biomarker for tracking the effectiveness of cancer treatments.

The identification of LINC01979 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases. Further research is needed to fully understand the role of LINC01979 in cellular processes and its potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1979

The "LINC01979 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01979 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets